Latest Breaking News On - Vaccine adjuvant development program - Page 1 : vimarsana.com

<p>Flu season is upon us, and existing vaccines are only ~40-60% effective at reducing the risk of serious illness.&nbsp;The <a href="https://www.childrenshospital.org/research/departments/pediatrics-research/precision-vaccines-program">Precision Vaccines Program</a> (PVP) at Boston Children&rsquo;s Hospital was awarded a Vaccine Adjuvant Development Program contract (75N93023C00040) from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) that can extend up to 5 years and $9 million, to develop a small molecule adjuvant to enhance the effectiveness of flu vaccines.</p> <p>&nbsp;</p>

United statesDana farber cancer instituteDavid dowlingJay evansNational institute of allergyNational institutes of healthPrecision vaccines programVaccine adjuvant development programUniversity of maryland school medicineUniversity of saskatchewanInternational vaccine centreBoston childrenNational institutesNational instituteInfectious diseasesOfer levy